Bioceres Crop Solutions Announces Board Changes Ahead of Strategic Growth Phase

Key Takeaways

• Noah Kolatch and Scott Crocco will join Bioceres’ Board of Directors effective June 24, 2025
• Gloria Montaron Estrada and Keith McGovern will step down after contributing to major company milestones
• CFO Enrique Lopez Lecube will rotate off the Board, with CCO Milen Marinov taking his place
• The new appointments bring financial, operational, and investment expertise to support Bioceres’ next phase
• The changes align with Bioceres’ long-term strategy following recent acquisitions and public market expansion

Bioceres Crop Solutions Appoints Two New Directors and Announces Board Transitions

Bioceres Crop Solutions Corp. (NASDAQ: BIOX), a company focused on developing agricultural solutions that enhance ecosystem resilience, has announced a series of changes to its Board of Directors, effective June 24, 2025. The updates are intended to support the company’s evolving strategic goals amid continued growth and operational scaling.

Noah Kolatch and Scott Crocco will join the Board as independent directors. At the same time, Gloria Montaron Estrada, a director since 2019, and Keith McGovern, who joined in 2022, will step down. Additionally, Chief Financial Officer Enrique Lopez Lecube will rotate off the Board, with Chief Commercial Officer Milen Marinov stepping into a board role.

Incoming Directors Bring Diverse Investment and Operational Backgrounds

Kolatch currently serves as a Principal at Jasper Lake LLC, a family investment office involved in both public and private markets. He previously held a partner role at Solel Partners, an investment firm with a focus on public equity and credit. He holds a BA in biochemistry from Columbia College.

Crocco brings over 30 years of financial and operational experience, including a long tenure at Air Products & Chemicals, Inc. (NYSE: APD), where he served as Chief Financial Officer and led corporate restructuring efforts. Most recently, he was CFO at Imperial Dade, a private equity-backed distribution company. Crocco holds degrees in electrical engineering and business administration from Bucknell University and Cornell University, respectively.

“We are confident that the deep experience, strategic insight and shared commitment of our new Board members will help us further refine our strategy and deliver value to shareholders and partners,” said Federico Trucco, CEO of Bioceres.

Departing Board Members Recognized for Key Contributions

The company acknowledged the contributions of outgoing directors Gloria Montaron Estrada and Keith McGovern.

“Gloria has been with Bioceres since before our public listing, initially as General Counsel and then as Board Member. She played a pivotal role in shaping our legal and regulatory strategy, including key milestones such as the Rizobacter acquisition and our IPO,” said Trucco.

Regarding McGovern, Trucco noted his involvement following Bioceres’ acquisition of Marrone Bio: “His insights have… helped us maintain a grounded, farmer-centric perspective on innovation and go-to-market efforts.”

Bioceres’ Internal Management Transition Reflects Continued Evolution

As part of the board restructuring, Chief Commercial Officer Milen Marinov will join the Board, replacing CFO Enrique Lopez Lecube. The company framed this change as part of a natural rotation within senior management aimed at bringing fresh commercial perspectives to board-level discussions.